期刊
NEUROPSYCHOPHARMACOLOGY
卷 22, 期 5, 页码 522-529出版社
NATURE PUBLISHING GROUP
DOI: 10.1016/S0893-133X(99)00144-X
关键词
adenosine A(2A) receptors; dopamine D-1 and D-2 receptors; Parkinson's disease; chronic caffeine treatment
In unilaterally 6-hydroxydopamine (6-OHDA)-lesioned rats, a rodent model of Parkinson's disease (PD), the adenosine A(2A) receptor antagonist SCH 58261 significantly increased (+180%, p<.01) the number of rotations induced by a low dose of quinpirole (a dopamine D-2 receptor agonist), while it did not significantly modify the effects of a comparably low dose of SKF 38393 (a dopamine D-1 receptor agonist). The dose-dependent potentiating effects of SCH 58261 on quinpirole-induced turning were similar in caffeine-treated rats (1 g/l in drinking water over 14 days) and control animals (tap water). The selective potentiating effects of SCH 58261 on D-2-dependent turning confirm the existence of a potent and specific A(2A)/D-2 receptor-receptor interaction. The persistence of the potentiating effects of SCH 58261 after chronic caffeine intake suggests that no tolerance should develop towards the antiparkinsonian effects of adenosine A(2A) receptor antagonists with chronic treatment. (C) American College of Neuropsychopharmacology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据